Alembic Pharmaceuticals advances on receiving USFDA’s approvals for ANDAs

22 Nov 2019 Evaluate

Alembic Pharmaceuticals is currently trading at Rs. 550.00, up by 3.50 points or 0.64% from its previous closing of Rs. 546.50 on the BSE.

The scrip opened at Rs. 551.00 and has touched a high and low of Rs. 559.10 and Rs. 545.50 respectively. So far 2149 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 636.50 on 03-Dec-2018 and a 52 week low of Rs. 435.10 on 21-Jun-2019.

Last one week high and low of the scrip stood at Rs. 561.00 and Rs. 543.00 respectively. The current market cap of the company is Rs. 10377.80 crore.

The promoters holding in the company stood at 72.97%, while Institutions and Non-Institutions held 15.97% and 11.06% respectively.

Alembic Pharmaceuticals has received approvals from US Food & Drug Administration (USFDA) for its Abbreviated New Drug Applications (ANDAs). The USFDA has given final approvals for Deferasirox Tablets 90 mg & 360 mg, Deferasirox Tablets for Oral Suspension, 125 mg, 250 mg, & 500 mg, and tentative approval for Deferasirox Tablets 180 mg.

Alembic now has a total of 107 ANDA approvals (95 final approvals and 12 tentative approvals) from USFDA.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

899.90 -2.30 (-0.25%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×